Carl Lee, MD
Otolaryngology · Swansea, ILNPI 1649273319
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,142 of the $1,890 with a category attached, or 60.4%. 9 manufacturers reported payments, led by Aerin Medical Inc. at 39.0% of the total. Reporting peaked in 2022 at $814 and has fallen 54.0% since, to $375 in 2025.
Across 32 payments — averaging $59.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$738
- Stryker$402
- Regeneron Healthcare Solutions, Inc.$232
- Astellas Pharma US Inc$156
- Sanofi$143
- Intersect ENT, Inc.$88
- plus $131 from 3 others
What the payments were for
- Travel & lodging$65034%
- Food & beverage$1,14260%
- Education$985%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 5 | $738 |
| Stryker | 8 | $402 |
| Regeneron Healthcare Solutions, Inc. | 4 | $232 |
| Astellas Pharma US Inc | 6 | $156 |
| Sanofi | 2 | $143 |
| Intersect ENT, Inc. | 2 | $88 |
| Integra Lifesciences Corporation | 2 | $63 |
| GSK | 2 | $47 |
| Optinose US, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,890 in reported general payments places this provider in the 60th percentile of 390 otolaryngology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 148 | $4,480 |
| Mometasone Furoate | 27 | $2,675 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 19 | $2,258 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 24 | $1,302 |
| Fluticasone Propionate | 73 | $889 |
| Fluocinolone Acetonide Oil | 13 | $656 |
| Cefdinir | 30 | $619 |
| Ofloxacin | 19 | $500 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 47 | $416 |
| Famotidine | 13 | $395 |
| Clotrimazole | 13 | $302 |
| Pantoprazole Sodium | 33 | $296 |
| Prednisone | 60 | $215 |
| Levocetirizine Dihydrochloride | 27 | $213 |
| CefuroximeCefuroxime Axetil | 14 | $208 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Swansea
- David ConleyChicago$630K
- Jayant PintoChicago$628K
- Robert KernChicago$610K
- Robert NaclerioBurr Ridge$229K
- Michael HutzOak Park$103K
- Charles WeingartenGlenview$96K
- Victoria LeeChicago$86K
- Louis PortugalChicago$68K
- Dean ToriumiChicago$63K
- Monica PatadiaChicago$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.